CVE-2025-61940 (GCVE-0-2025-61940)
Vulnerability from cvelistv5 – Published: 2025-12-02 21:07 – Updated: 2025-12-02 21:39
VLAI?
Summary
NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.
Severity ?
CWE
Assigner
References
Impacted products
| Vendor | Product | Version | ||
|---|---|---|---|---|
| Mirion Medical | EC2 Software NMIS BioDose |
Affected:
0 , < 23.0
(custom)
Unaffected: 23.0 |
Credits
Joe Dillon reported these vulnerabilities to Mirion Medical.
{
"containers": {
"adp": [
{
"metrics": [
{
"other": {
"content": {
"id": "CVE-2025-61940",
"options": [
{
"Exploitation": "none"
},
{
"Automatable": "no"
},
{
"Technical Impact": "partial"
}
],
"role": "CISA Coordinator",
"timestamp": "2025-12-02T21:39:17.758822Z",
"version": "2.0.3"
},
"type": "ssvc"
}
}
],
"providerMetadata": {
"dateUpdated": "2025-12-02T21:39:30.055Z",
"orgId": "134c704f-9b21-4f2e-91b3-4a467353bcc0",
"shortName": "CISA-ADP"
},
"title": "CISA ADP Vulnrichment"
}
],
"cna": {
"affected": [
{
"defaultStatus": "unaffected",
"product": "EC2 Software NMIS BioDose",
"vendor": "Mirion Medical",
"versions": [
{
"lessThan": "23.0",
"status": "affected",
"version": "0",
"versionType": "custom"
},
{
"status": "unaffected",
"version": "23.0"
}
]
}
],
"credits": [
{
"lang": "en",
"type": "finder",
"value": "Joe Dillon reported these vulnerabilities to Mirion Medical."
}
],
"datePublic": "2025-12-02T17:00:00.000Z",
"descriptions": [
{
"lang": "en",
"supportingMedia": [
{
"base64": false,
"type": "text/html",
"value": "\u003cspan style=\"background-color: rgb(255, 255, 255);\"\u003e\n\n\u003cspan style=\"background-color: rgb(255, 255, 255);\"\u003e\n\n\u003cspan style=\"background-color: rgb(255, 255, 255);\"\u003eNMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.\u003c/span\u003e\n\n\u003c/span\u003e\n\n\u003c/span\u003e"
}
],
"value": "NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection."
}
],
"metrics": [
{
"cvssV4_0": {
"Automatable": "NOT_DEFINED",
"Recovery": "NOT_DEFINED",
"Safety": "NOT_DEFINED",
"attackComplexity": "LOW",
"attackRequirements": "NONE",
"attackVector": "NETWORK",
"baseScore": 8.7,
"baseSeverity": "HIGH",
"exploitMaturity": "NOT_DEFINED",
"privilegesRequired": "LOW",
"providerUrgency": "NOT_DEFINED",
"subAvailabilityImpact": "NONE",
"subConfidentialityImpact": "NONE",
"subIntegrityImpact": "NONE",
"userInteraction": "NONE",
"valueDensity": "NOT_DEFINED",
"vectorString": "CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N",
"version": "4.0",
"vulnAvailabilityImpact": "LOW",
"vulnConfidentialityImpact": "HIGH",
"vulnIntegrityImpact": "HIGH",
"vulnerabilityResponseEffort": "NOT_DEFINED"
},
"format": "CVSS",
"scenarios": [
{
"lang": "en",
"value": "GENERAL"
}
]
},
{
"cvssV3_1": {
"attackComplexity": "LOW",
"attackVector": "NETWORK",
"availabilityImpact": "LOW",
"baseScore": 8.3,
"baseSeverity": "HIGH",
"confidentialityImpact": "HIGH",
"integrityImpact": "HIGH",
"privilegesRequired": "LOW",
"scope": "UNCHANGED",
"userInteraction": "NONE",
"vectorString": "CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L",
"version": "3.1"
},
"format": "CVSS",
"scenarios": [
{
"lang": "en",
"value": "GENERAL"
}
]
}
],
"problemTypes": [
{
"descriptions": [
{
"cweId": "CWE-603",
"description": "CWE-603",
"lang": "en",
"type": "CWE"
}
]
}
],
"providerMetadata": {
"dateUpdated": "2025-12-02T21:07:47.995Z",
"orgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
"shortName": "icscert"
},
"references": [
{
"url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01"
}
],
"solutions": [
{
"lang": "en",
"supportingMedia": [
{
"base64": false,
"type": "text/html",
"value": "\u003cspan style=\"background-color: rgb(255, 255, 255);\"\u003eMirion Medical recommends users update to V23.0 or later. Users with an active support contract should update to the latest version through the software or users can contact \u003c/span\u003e\u003ca target=\"_blank\" rel=\"nofollow\"\u003eMirion Medical support\u003c/a\u003e\u003cspan style=\"background-color: rgb(255, 255, 255);\"\u003e\u0026nbsp;directly.\u003c/span\u003e\n\n\u003cbr\u003e"
}
],
"value": "Mirion Medical recommends users update to V23.0 or later. Users with an active support contract should update to the latest version through the software or users can contact Mirion Medical support\u00a0directly."
}
],
"source": {
"advisory": "ICSMA-25-336-01",
"discovery": "EXTERNAL"
},
"title": "Mirion Medical EC2 Software NMIS BioDose Use of Client-Side Authentication",
"x_generator": {
"engine": "Vulnogram 0.5.0"
}
}
},
"cveMetadata": {
"assignerOrgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
"assignerShortName": "icscert",
"cveId": "CVE-2025-61940",
"datePublished": "2025-12-02T21:07:47.995Z",
"dateReserved": "2025-11-11T20:56:52.843Z",
"dateUpdated": "2025-12-02T21:39:30.055Z",
"state": "PUBLISHED"
},
"dataType": "CVE_RECORD",
"dataVersion": "5.2",
"vulnerability-lookup:meta": {
"nvd": "{\"cve\":{\"id\":\"CVE-2025-61940\",\"sourceIdentifier\":\"ics-cert@hq.dhs.gov\",\"published\":\"2025-12-02T21:15:51.930\",\"lastModified\":\"2025-12-04T17:15:08.283\",\"vulnStatus\":\"Awaiting Analysis\",\"cveTags\":[],\"descriptions\":[{\"lang\":\"en\",\"value\":\"NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.\"}],\"metrics\":{\"cvssMetricV40\":[{\"source\":\"ics-cert@hq.dhs.gov\",\"type\":\"Secondary\",\"cvssData\":{\"version\":\"4.0\",\"vectorString\":\"CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X\",\"baseScore\":8.7,\"baseSeverity\":\"HIGH\",\"attackVector\":\"NETWORK\",\"attackComplexity\":\"LOW\",\"attackRequirements\":\"NONE\",\"privilegesRequired\":\"LOW\",\"userInteraction\":\"NONE\",\"vulnConfidentialityImpact\":\"HIGH\",\"vulnIntegrityImpact\":\"HIGH\",\"vulnAvailabilityImpact\":\"LOW\",\"subConfidentialityImpact\":\"NONE\",\"subIntegrityImpact\":\"NONE\",\"subAvailabilityImpact\":\"NONE\",\"exploitMaturity\":\"NOT_DEFINED\",\"confidentialityRequirement\":\"NOT_DEFINED\",\"integrityRequirement\":\"NOT_DEFINED\",\"availabilityRequirement\":\"NOT_DEFINED\",\"modifiedAttackVector\":\"NOT_DEFINED\",\"modifiedAttackComplexity\":\"NOT_DEFINED\",\"modifiedAttackRequirements\":\"NOT_DEFINED\",\"modifiedPrivilegesRequired\":\"NOT_DEFINED\",\"modifiedUserInteraction\":\"NOT_DEFINED\",\"modifiedVulnConfidentialityImpact\":\"NOT_DEFINED\",\"modifiedVulnIntegrityImpact\":\"NOT_DEFINED\",\"modifiedVulnAvailabilityImpact\":\"NOT_DEFINED\",\"modifiedSubConfidentialityImpact\":\"NOT_DEFINED\",\"modifiedSubIntegrityImpact\":\"NOT_DEFINED\",\"modifiedSubAvailabilityImpact\":\"NOT_DEFINED\",\"Safety\":\"NOT_DEFINED\",\"Automatable\":\"NOT_DEFINED\",\"Recovery\":\"NOT_DEFINED\",\"valueDensity\":\"NOT_DEFINED\",\"vulnerabilityResponseEffort\":\"NOT_DEFINED\",\"providerUrgency\":\"NOT_DEFINED\"}}],\"cvssMetricV31\":[{\"source\":\"ics-cert@hq.dhs.gov\",\"type\":\"Secondary\",\"cvssData\":{\"version\":\"3.1\",\"vectorString\":\"CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L\",\"baseScore\":8.3,\"baseSeverity\":\"HIGH\",\"attackVector\":\"NETWORK\",\"attackComplexity\":\"LOW\",\"privilegesRequired\":\"LOW\",\"userInteraction\":\"NONE\",\"scope\":\"UNCHANGED\",\"confidentialityImpact\":\"HIGH\",\"integrityImpact\":\"HIGH\",\"availabilityImpact\":\"LOW\"},\"exploitabilityScore\":2.8,\"impactScore\":5.5}]},\"weaknesses\":[{\"source\":\"ics-cert@hq.dhs.gov\",\"type\":\"Primary\",\"description\":[{\"lang\":\"en\",\"value\":\"CWE-603\"}]}],\"references\":[{\"url\":\"https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01\",\"source\":\"ics-cert@hq.dhs.gov\"}]}}",
"vulnrichment": {
"containers": "{\"adp\": [{\"title\": \"CISA ADP Vulnrichment\", \"metrics\": [{\"other\": {\"type\": \"ssvc\", \"content\": {\"id\": \"CVE-2025-61940\", \"role\": \"CISA Coordinator\", \"options\": [{\"Exploitation\": \"none\"}, {\"Automatable\": \"no\"}, {\"Technical Impact\": \"partial\"}], \"version\": \"2.0.3\", \"timestamp\": \"2025-12-02T21:39:17.758822Z\"}}}], \"providerMetadata\": {\"orgId\": \"134c704f-9b21-4f2e-91b3-4a467353bcc0\", \"shortName\": \"CISA-ADP\", \"dateUpdated\": \"2025-12-02T21:39:24.460Z\"}}], \"cna\": {\"title\": \"Mirion Medical EC2 Software NMIS BioDose Use of Client-Side Authentication\", \"source\": {\"advisory\": \"ICSMA-25-336-01\", \"discovery\": \"EXTERNAL\"}, \"credits\": [{\"lang\": \"en\", \"type\": \"finder\", \"value\": \"Joe Dillon reported these vulnerabilities to Mirion Medical.\"}], \"metrics\": [{\"format\": \"CVSS\", \"cvssV4_0\": {\"Safety\": \"NOT_DEFINED\", \"version\": \"4.0\", \"Recovery\": \"NOT_DEFINED\", \"baseScore\": 8.7, \"Automatable\": \"NOT_DEFINED\", \"attackVector\": \"NETWORK\", \"baseSeverity\": \"HIGH\", \"valueDensity\": \"NOT_DEFINED\", \"vectorString\": \"CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N\", \"exploitMaturity\": \"NOT_DEFINED\", \"providerUrgency\": \"NOT_DEFINED\", \"userInteraction\": \"NONE\", \"attackComplexity\": \"LOW\", \"attackRequirements\": \"NONE\", \"privilegesRequired\": \"LOW\", \"subIntegrityImpact\": \"NONE\", \"vulnIntegrityImpact\": \"HIGH\", \"subAvailabilityImpact\": \"NONE\", \"vulnAvailabilityImpact\": \"LOW\", \"subConfidentialityImpact\": \"NONE\", \"vulnConfidentialityImpact\": \"HIGH\", \"vulnerabilityResponseEffort\": \"NOT_DEFINED\"}, \"scenarios\": [{\"lang\": \"en\", \"value\": \"GENERAL\"}]}, {\"format\": \"CVSS\", \"cvssV3_1\": {\"scope\": \"UNCHANGED\", \"version\": \"3.1\", \"baseScore\": 8.3, \"attackVector\": \"NETWORK\", \"baseSeverity\": \"HIGH\", \"vectorString\": \"CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L\", \"integrityImpact\": \"HIGH\", \"userInteraction\": \"NONE\", \"attackComplexity\": \"LOW\", \"availabilityImpact\": \"LOW\", \"privilegesRequired\": \"LOW\", \"confidentialityImpact\": \"HIGH\"}, \"scenarios\": [{\"lang\": \"en\", \"value\": \"GENERAL\"}]}], \"affected\": [{\"vendor\": \"Mirion Medical\", \"product\": \"EC2 Software NMIS BioDose\", \"versions\": [{\"status\": \"affected\", \"version\": \"0\", \"lessThan\": \"23.0\", \"versionType\": \"custom\"}, {\"status\": \"unaffected\", \"version\": \"23.0\"}], \"defaultStatus\": \"unaffected\"}], \"solutions\": [{\"lang\": \"en\", \"value\": \"Mirion Medical recommends users update to V23.0 or later. Users with an active support contract should update to the latest version through the software or users can contact Mirion Medical support\\u00a0directly.\", \"supportingMedia\": [{\"type\": \"text/html\", \"value\": \"\u003cspan style=\\\"background-color: rgb(255, 255, 255);\\\"\u003eMirion Medical recommends users update to V23.0 or later. Users with an active support contract should update to the latest version through the software or users can contact \u003c/span\u003e\u003ca target=\\\"_blank\\\" rel=\\\"nofollow\\\"\u003eMirion Medical support\u003c/a\u003e\u003cspan style=\\\"background-color: rgb(255, 255, 255);\\\"\u003e\u0026nbsp;directly.\u003c/span\u003e\\n\\n\u003cbr\u003e\", \"base64\": false}]}], \"datePublic\": \"2025-12-02T17:00:00.000Z\", \"references\": [{\"url\": \"https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01\"}], \"x_generator\": {\"engine\": \"Vulnogram 0.5.0\"}, \"descriptions\": [{\"lang\": \"en\", \"value\": \"NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.\", \"supportingMedia\": [{\"type\": \"text/html\", \"value\": \"\u003cspan style=\\\"background-color: rgb(255, 255, 255);\\\"\u003e\\n\\n\u003cspan style=\\\"background-color: rgb(255, 255, 255);\\\"\u003e\\n\\n\u003cspan style=\\\"background-color: rgb(255, 255, 255);\\\"\u003eNMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.\u003c/span\u003e\\n\\n\u003c/span\u003e\\n\\n\u003c/span\u003e\", \"base64\": false}]}], \"problemTypes\": [{\"descriptions\": [{\"lang\": \"en\", \"type\": \"CWE\", \"cweId\": \"CWE-603\", \"description\": \"CWE-603\"}]}], \"providerMetadata\": {\"orgId\": \"7d14cffa-0d7d-4270-9dc0-52cabd5a23a6\", \"shortName\": \"icscert\", \"dateUpdated\": \"2025-12-02T21:07:47.995Z\"}}}",
"cveMetadata": "{\"cveId\": \"CVE-2025-61940\", \"state\": \"PUBLISHED\", \"dateUpdated\": \"2025-12-02T21:39:30.055Z\", \"dateReserved\": \"2025-11-11T20:56:52.843Z\", \"assignerOrgId\": \"7d14cffa-0d7d-4270-9dc0-52cabd5a23a6\", \"datePublished\": \"2025-12-02T21:07:47.995Z\", \"assignerShortName\": \"icscert\"}",
"dataType": "CVE_RECORD",
"dataVersion": "5.2"
}
}
}
Loading…
Loading…
Sightings
| Author | Source | Type | Date |
|---|
Nomenclature
- Seen: The vulnerability was mentioned, discussed, or observed by the user.
- Confirmed: The vulnerability has been validated from an analyst's perspective.
- Published Proof of Concept: A public proof of concept is available for this vulnerability.
- Exploited: The vulnerability was observed as exploited by the user who reported the sighting.
- Patched: The vulnerability was observed as successfully patched by the user who reported the sighting.
- Not exploited: The vulnerability was not observed as exploited by the user who reported the sighting.
- Not confirmed: The user expressed doubt about the validity of the vulnerability.
- Not patched: The vulnerability was not observed as successfully patched by the user who reported the sighting.
Loading…
Loading…